Market Place
Sourcing Support
All News #Library
Biotech
Harmony Bio Appoints Glenn Reicin As Cfo
14 Apr 2026 //
PHARMIWEB
Harmony Biosciences Joins Investor Conferences
04 Mar 2026 //
PHARMIWEB
Harmony Biosciences Issues Strong 2025, $1B+ 2026 Guidance
24 Feb 2026 //
PHARMIWEB
Harmony Biosciences Targets $1B+ WAKIX Revenue by 2026
12 Jan 2026 //
PHARMIWEB
Harmony`s Dravet Drug Halves Monthly Seizures In Late-Stage Study
03 Dec 2025 //
BIOSPACE
Harmony Biosciences Unveils Phase 3 ARGUS Trial Extension Data
02 Dec 2025 //
BUSINESSWIRE
Harmony Announces Positive Bioequivalence Data For Pitolisant
24 Nov 2025 //
BUSINESSWIRE
Harmony Starts First-In-Human Study Of Orexin 2 Agonist BP1.15205
19 Nov 2025 //
BUSINESSWIRE
Harmony Biosciences Reports Strong Q3 2025 Financial Results
04 Nov 2025 //
BUSINESSWIRE
Harmony Halts Genetic Disease Program After Ph. 3 Failure
04 Nov 2025 //
FIERCE BIOTECH
Harmony Updates SNDA Status For Pitolisant In Idiopathic Hypersomnia
19 Feb 2025 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.